Elanco Animal Health (ELAN) Prepaid Assets (2017 - 2026)
Elanco Animal Health (ELAN) reported Prepaid Assets of $285.0 million for Q1 2026, down 5.32% on a YoY basis from $301.0 million in Q1 2025, and up 20.76% sequentially from $236.0 million in Q4 2025.
Elanco Animal Health (ELAN) Prepaid Assets (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Prepaid Assets data on file, last reported at $285.0 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 5.32% year-over-year to $285.0 million; the trailing twelve-month figure through Mar 2026 stood at $285.0 million (down 5.32% YoY), and the FY2025 full-year result was $236.0 million, down 17.77% from the prior year.
- Prepaid Assets improved to $285.0 million in Q1 2026, from $236.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $394.0 million in Q4 2022 to a low of $236.0 million in Q4 2025.
- A 5-year average of $321.5 million and a median of $315.0 million in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 66.24% in 2022 and declined 25.14% in 2024, its largest moves.
- Tracing ELAN's Prepaid Assets over 5 years: stood at $394.0 million in 2022, then dropped by 21.32% to $310.0 million in 2023, then retreated by 7.42% to $287.0 million in 2024, then declined by 17.77% to $236.0 million in 2025, then increased by 20.76% to $285.0 million in 2026.
- Business Quant data shows ELAN's Prepaid Assets at $285.0 million in Q1 2026, $236.0 million in Q4 2025, and $305.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 285.00 Mn |
| Dec 31, 2025 | 236.00 Mn |
| Sep 30, 2025 | 305.00 Mn |
| Jun 30, 2025 | 302.00 Mn |
| Mar 31, 2025 | 301.00 Mn |
| Dec 31, 2024 | 287.00 Mn |
| Sep 30, 2024 | 340.00 Mn |
| Jun 30, 2024 | 277.00 Mn |
| Mar 31, 2024 | 338.00 Mn |
| Dec 31, 2023 | 310.00 Mn |
| Sep 30, 2023 | 371.00 Mn |
| Jun 30, 2023 | 370.00 Mn |
| Mar 31, 2023 | 370.00 Mn |
| Dec 31, 2022 | 394.00 Mn |
| Sep 30, 2022 | 326.00 Mn |
| Jun 30, 2022 | 338.00 Mn |
| Mar 31, 2022 | 315.00 Mn |
| Dec 31, 2021 | 237.00 Mn |
| Sep 30, 2021 | 242.00 Mn |
| Jun 30, 2021 | 227.00 Mn |